Transamerica Financial Advisors LLC Invests $3.26 Million in Axon Enterprise, Inc $AXON

Transamerica Financial Advisors LLC purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 5,807 shares of the biotechnology company’s stock, valued at approximately $3,256,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Darwin Wealth Management LLC bought a new position in Axon Enterprise during the second quarter worth about $37,000. Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise in the 4th quarter valued at about $28,000. Camelot Portfolios LLC bought a new stake in Axon Enterprise in the 4th quarter valued at about $30,000. Keating Financial Advisory Services Inc. acquired a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $31,000. Finally, AlphaCentric Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $34,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

AXON has been the subject of several recent research reports. UBS Group boosted their price target on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Piper Sandler raised their price objective on Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Barclays lifted their price objective on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. raised their price target on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $730.92.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $607.48 on Thursday. The company has a 50 day moving average of $553.45 and a 200-day moving average of $480.77. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $794.29. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The company has a market cap of $49.35 billion, a PE ratio of 252.07, a price-to-earnings-growth ratio of 9.95 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. The business had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm’s revenue for the quarter was up 35.3% on a year-over-year basis. During the same quarter last year, the business posted $2.12 EPS. As a group, equities research analysts forecast that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the sale, the president owned 169,125 shares of the company’s stock, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 9,605 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the transaction, the insider directly owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This trade represents a 8.95% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 76,594 shares of company stock worth $41,236,386. 4.20% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.